A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine profile
Authors:
- 3 April 2021
- journal article
- case report
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
- Vol. 5 (2) , 442-447
Abstract
The new disease concept of multisystem inflammatory syndrome in children (MIS-C), which is a systemic inflammatory syndrome with multiple organ involvement after SARS-CoV2 infection, was established in 2020. MIS-C is common in Hispanic and black children in Europe and North America, with few reports in East Asians. A significant portion of patients with MIS-C develop Kawasaki disease (KD)-like symptoms. Therefore, differential diagnosis is challenging, especially in East Asia, where KD is most prevalent. No Japanese cases have been reported in the literatures so far. We report a case of MIS-C in Japan with KD-like symptoms. A 9-year-old Japanese boy, who was infected with SARS-CoV2 1 month previously along with his family, was admitted to our hospital owing to fever for 6 days and erythema mainly in the groyne and pubic area. He also had conjunctivitis, strawberry tongue, and diarrhoea. His laboratory findings were as follows: WBC, 12,840/µL (lymphocytes, 4%); CRP, 22.6 mg/dL, pro-calcitonin, 1.8 ng/mL (normal, <0.50 ng/mL); NT pro-BNP, 7627 pg/mL (<125 pg/mL); and troponin T, 0.14 ng/mL (<0.01 ng/mL). His cardiac function was normal. We initially diagnosed him with KD. His fever rapidly resolved with intravenous immunoglobulin and there were no coronary artery lesions. Desquamation of the fingers was observed later. Finally, a history of SARS-COV2 infection, his age, atypical skin rash, elevation of markers of inflammation and heart failure, and lymphopenia suggested the diagnosis of MIS-C rather than KD. Differentiation between KD and MIS-C is necessary even in Japan, especially in patients with atypical features of KD.Keywords
This publication has 17 references indexed in Scilit:
- COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1Arthritis & Rheumatology, 2020
- Multisystem Inflammatory Syndrome in U.S. Children and AdolescentsNew England Journal of Medicine, 2020
- Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2JAMA, 2020
- Epidemiology of COVID-19 Among Children in ChinaPediatrics, 2020
- Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysisJournal of the Formosan Medical Association, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchangeCytokine, 2014
- The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki diseaseClinical and Experimental Immunology, 2010
- Natriuretic Peptide as an Adjunctive Diagnostic Test in the Acute Phase of Kawasaki DiseasePediatric Cardiology, 2009